Mutapi Francisca, Mduluza Takafira, Gomez-Escobar Natalia, Gregory William F, Fernandez Cecilia, Midzi Nicholas, Maizels Rick M
Institute of Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King's Buildings, West Mains Rd, Edinburgh, EH9 3J, UK.
BMC Infect Dis. 2006 Jun 9;6:96. doi: 10.1186/1471-2334-6-96.
Schistosomiasis is a major parasitic disease affecting over 200 million people in the developing world with a further 400 million people at risk of infection. The aim of this study was to identify a single antigen from adult Schistosoma haematobium worms and subsequently use this antigen to study the development of schistosome-acquired immunity in a human population.
The full-length cDNA sequence of a S. haematobium protein, a putative orthologue of the S. mansoni tegumental antigen Sm13, was obtained from a cDNA library of adult S. haematobium worms and named Sh13 following a small-scale expressed sequence tags (EST) project. The recombinant Sh13 protein expressed in E. coli, was used to investigate immuno-epidemiological patterns in 147 Zimbabweans (7-18 years old) exposed to S. haematobium.
Sequence analysis of the full-length cDNA sequence of the S. haematobium protein Sh13, indicated that the protein has an N-terminal signal peptide and encodes an 85-amino acid mature protein with a highly conserved predicted transmembrane domain (86 % identity with the S. mansoni tegumental antigen Sm13). The recombinant Sh13 protein was used in ELISA assays to determine the reactivity of sera from the study participants. Antibody responses against Sh13 were predominantly IgG3 isotype compared to responses against crude worm antigens which were predominantly IgG1 and IgG4. The relationship between anti-Sh13 IgG3 levels and infection intensity varied significantly with host age. The youngest children (7-10 years old) had relatively low levels of both infection and anti-Sh13 IgG3. In older children (11-12 years old) rising infection levels were accompanied by a significant increase in anti-Sh13 IgG3 levels. Subsequently, infection intensity declined significantly in 13-18 year olds but levels of the antibody continued to rise. The changing relationship between infection intensity and anti-Sh13 IgG3 levels with host age is consistent with the profile of a protective immune response predicted from theoretical work.
We have identified and characterised a novel S. haematobium antigen Sh13, a putative tegumental protein, and shown that it is recognised predominantly by IgG3 antibodies from people infected with/exposed to S. haematobium parasites. We have also shown that, the anti-Sh13 IgG3 response is maximal in older individuals with the lowest infection intensity, and that the age profile of the relationship between anti-Sh13 IgG3 and infection intensity is consistent with that predicted by theoretical work for a protective response stimulated by and directed against adult worms.
血吸虫病是一种主要的寄生虫病,影响着发展中世界超过2亿人,另有4亿人面临感染风险。本研究的目的是从埃及血吸虫成虫中鉴定出一种单一抗原,随后用该抗原研究人群中血吸虫获得性免疫的发展情况。
从埃及血吸虫成虫的cDNA文库中获得一种埃及血吸虫蛋白的全长cDNA序列,该蛋白是曼氏血吸虫体表抗原Sm13的假定同源物,在一个小规模表达序列标签(EST)项目后将其命名为Sh13。在大肠杆菌中表达的重组Sh13蛋白用于调查147名暴露于埃及血吸虫的津巴布韦人(7 - 18岁)的免疫流行病学模式。
埃及血吸虫蛋白Sh13全长cDNA序列的分析表明,该蛋白具有一个N端信号肽,编码一个85个氨基酸的成熟蛋白,具有高度保守的预测跨膜结构域(与曼氏血吸虫体表抗原Sm13有86%的同一性)。重组Sh13蛋白用于酶联免疫吸附测定(ELISA)以确定研究参与者血清的反应性。与针对粗制虫体抗原的反应(主要是IgG1和IgG4)相比,针对Sh13的抗体反应主要是IgG3亚型。抗Sh13 IgG3水平与感染强度之间的关系随宿主年龄有显著变化。最年幼的儿童(7 - 10岁)感染水平和抗Sh13 IgG3水平相对较低。在年龄较大的儿童(11 - 12岁)中,感染水平上升伴随着抗Sh13 IgG3水平的显著增加。随后,13 - 18岁青少年的感染强度显著下降,但抗体水平继续上升。感染强度与抗Sh13 IgG3水平之间随宿主年龄变化的关系与理论研究预测的保护性免疫反应特征一致。
我们已经鉴定并表征了一种新型埃及血吸虫抗原Sh13,一种假定的体表蛋白,并表明它主要被感染/暴露于埃及血吸虫寄生虫的人的IgG3抗体识别。我们还表明,抗Sh13 IgG3反应在感染强度最低的年长个体中最大,并且抗Sh13 IgG3与感染强度之间关系的年龄特征与理论研究预测的由成虫刺激并针对成虫的保护性反应一致。